FDC Limited FDC.BO BSE · Healthcare · India
₹371.75 -4.80% -₹18.75
Summary
64 / 100 · Bulios Score
What speaks for it
- Out of every 100 INR of revenue, 14 INR is left as net profit.
- It holds more cash than debt: ₹472.3M against ₹128.2M.
- Earnings per share grew by 14% a year over the last 3 years.
What to watch
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 20.3 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (INR)
Diluted EPS (INR)
- Analyst estimate
Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 6.8% a year. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 INR of revenue goes
- Cost of sales 57 INR
- Sales and administration 29 INR
- Taxes and other 0.3 INR
- Net profit 14 INR
Net profit, industry median (Drug Manufacturers - Specialty & Generic) 9.9 INR
Out of every 100 INR of revenue, 14 INR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail